No Data
No Data
No Data
No Data
No Data
Earnings Preview: Bristol Myers Squibb (BMY) Q1 Earnings Expected to Decline
Yahoo FinanceApr 18 10:01 ET
Buy Rating Affirmed for BioMarin Pharmaceutical Amidst Strong Sales Outlook and Optimized Market Expectations
TipRanksApr 15 19:35 ET
Biomarin Pharmaceutical(BMRN.US) Director Sells US$3.65 Million in Common Stock
$Biomarin Pharmaceutical(BMRN.US)$ Director BIENAIME JEAN JACQUES sold 40,000 shares of common stock on Apr 11, 12, 2024 at an average price of $91.13 for a total value of $3.65 million.Source: Announ
moomoo NewsApr 15 17:04 ET
Biomarin Pharmaceutical Insider Sold Shares Worth $3,645,000, According to a Recent SEC Filing
Jean Jacques Bienaime, Director, on April 11, 2024, sold 40,000 shares in Biomarin Pharmaceutical (BMRN) for $3,645,000. Following the Form 4 filing with the SEC, Bienaime has control over a total of
MT NewswiresApr 15 16:26 ET
BioMarin Pharmaceutical (NASDAQ:BMRN) Investors Are up 5.7% in the Past Week, but Earnings Have Declined Over the Last Three Years
By buying an index fund, you can roughly match the market return with ease. But many of us dare to dream of bigger returns, and build a portfolio ourselves. For example, the BioMarin Pharmaceutical
Simply Wall StApr 15 09:24 ET
Insider Sell: Biomarin Pharmaceutical Inc (BMRN) Chief Accounting Officer Erin Burkhart ...
Yahoo FinanceApr 12 19:00 ET
No Data
No Data